Meeting
2014 Genitourinary Cancers Symposium
What is the optimal management of Gleason score 7 (GS7) prostate cancer (PC) at biopsy? A comparison of disease control for prostatectomy (RP) versus radiation therapy (RT).
Authors
John Morgan Watkins
Bismarck Cancer Center, Bismarck, ND
John Morgan Watkins , Patricia L. Watkins , Tarek A. Dufan , Nadim Koleilat
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 250)
DOI
10.1200/jco.2014.32.4_suppl.250
Abstract #
250
Poster Bd #
D18
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Advancing age and the risk of adverse pathology at radical prostatectomy in men with biopsy Gleason score 6 prostate cancer.
First Author: Daniel Kim
Poster
2018 Genitourinary Cancers Symposium
Heterogeneity in early oncologic outcomes among men with NCCN intermediate-risk prostate cancer treated with radical prostatectomy.
First Author: Kamyar Ghabili
Poster
2015 Genitourinary Cancers Symposium
Treatment outcomes of radiotherapy versus prostatectomy for localized prostate cancer with Gleason 8 or more on biopsy.
First Author: Christopher Baker Jr.
Poster
2022 ASCO Genitourinary Cancers Symposium
Outcomes and factors associated with reclassification in a multiethnic cohort enrolled in active surveillance for prostate cancer.
First Author: Denzel Zhu